PRTC
Price
$19.00
Change
+$0.40 (+2.15%)
Updated
Jun 6 closing price
Capitalization
456.97M
17 days until earnings call
ZLAB
Price
$38.11
Change
+$1.57 (+4.30%)
Updated
Jun 6 closing price
Capitalization
4.14B
65 days until earnings call
Interact to see
Advertisement

PRTC vs ZLAB

Header iconPRTC vs ZLAB Comparison
Open Charts PRTC vs ZLABBanner chart's image
PureTech Health
Price$19.00
Change+$0.40 (+2.15%)
Volume$1.13K
Capitalization456.97M
Zai Lab
Price$38.11
Change+$1.57 (+4.30%)
Volume$1.06M
Capitalization4.14B
PRTC vs ZLAB Comparison Chart
Loading...
ZLAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRTC vs. ZLAB commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRTC is a Hold and ZLAB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (PRTC: $19.00 vs. ZLAB: $38.11)
Brand notoriety: PRTC and ZLAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRTC: 18% vs. ZLAB: 80%
Market capitalization -- PRTC: $456.97M vs. ZLAB: $4.14B
PRTC [@Biotechnology] is valued at $456.97M. ZLAB’s [@Biotechnology] market capitalization is $4.14B. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRTC’s FA Score shows that 0 FA rating(s) are green whileZLAB’s FA Score has 0 green FA rating(s).

  • PRTC’s FA Score: 0 green, 5 red.
  • ZLAB’s FA Score: 0 green, 5 red.
According to our system of comparison, ZLAB is a better buy in the long-term than PRTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ZLAB’s TA Score shows that 6 TA indicator(s) are bullish.

  • ZLAB’s TA Score: 6 bullish, 4 bearish.

Price Growth

PRTC (@Biotechnology) experienced а +3.09% price change this week, while ZLAB (@Biotechnology) price change was +26.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

PRTC is expected to report earnings on Aug 27, 2025.

ZLAB is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZLAB($4.14B) has a higher market cap than PRTC($457M). ZLAB YTD gains are higher at: 45.514 vs. PRTC (2.925). PRTC has higher annual earnings (EBITDA): -53.65M vs. ZLAB (-236.44M). ZLAB has more cash in the bank: 757M vs. PRTC (502M). PRTC has less debt than ZLAB: PRTC (24M) vs ZLAB (192M). ZLAB has higher revenues than PRTC: ZLAB (418M) vs PRTC (0).
PRTCZLABPRTC / ZLAB
Capitalization457M4.14B11%
EBITDA-53.65M-236.44M23%
Gain YTD2.92545.5146%
P/E Ratio9.05N/A-
Revenue0418M-
Total Cash502M757M66%
Total Debt24M192M13%
FUNDAMENTALS RATINGS
ZLAB: Fundamental Ratings
ZLAB
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ZLAB
RSI
ODDS (%)
Bearish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 11 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ZLAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MGMT39.220.72
+1.87%
Ballast Small/Mid Cap ETF
JPEF68.430.53
+0.78%
JPMorgan Equity Focus ETF
FCO6.290.03
+0.48%
abrdn Global Income Fund
SAY25.28-0.02
-0.08%
Saratoga Investment Corp
HTAB18.54-0.12
-0.64%
Hartford Schroders Tax-Aware Bond ETF

PRTC and

Correlation & Price change

A.I.dvisor tells us that PRTC and AUTL have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRTC and AUTL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTC
1D Price
Change %
PRTC100%
+2.15%
AUTL - PRTC
32%
Poorly correlated
+3.54%
RLMD - PRTC
31%
Poorly correlated
+1.82%
PTCHF - PRTC
29%
Poorly correlated
N/A
ZLAB - PRTC
28%
Poorly correlated
+4.30%
IRON - PRTC
27%
Poorly correlated
+5.71%
More

ZLAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLAB has been loosely correlated with ONC. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLAB jumps, then ONC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLAB
1D Price
Change %
ZLAB100%
+4.30%
ONC - ZLAB
53%
Loosely correlated
-0.44%
MGTX - ZLAB
38%
Loosely correlated
+9.49%
ATXS - ZLAB
36%
Loosely correlated
+14.75%
VERV - ZLAB
36%
Loosely correlated
+8.12%
ABCL - ZLAB
35%
Loosely correlated
+2.95%
More